Completed NA INTERVENTIONAL 1-arm NCT03802708

Fetal Alcohol Spectrum Disorder-Is This a Ciliopathy?

Sponsor: University of Alberta

Conditions Fetal Alcohol Spectrum Disorder

Interventions Metabolomic analysis urine sample

Updated 5 times since 2019 Last updated: Mar 23, 2020 Started: Sep 1, 2018 Primary completion: Jan 1, 2020 Completion: Mar 23, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Fetal Alcohol Spectrum Disorder, this trial is completed. The trial is conducted by University of Alberta and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2019 — Apr 2020 [monthly]

Recruiting NA

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Alberta

Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada